|
Program - Summary:
Startup Capital in DC: Perspectives on Challenges & Opportunities
Expert speakers - including a venture capitalist, startup firm officer, attorney and one of top tech journalists - will cover various business, finance and legal aspects of:
VC funding
Crowdfunding
The JOBS Act recently signed into law that lowers regulatory burdens many companies would otherwise face in raising capital
Angels
Schedule:
5:30-6:30 pm: Networking and Light Dinner
6:30-7:30 pm: Intros. Then each panelist presents for 10 minutes (40 minutes of presentations) followed by 20 minutes of Q&A.
7:30-7:45 pm: Wrap-up with note from Jamey Jeff on new Wharton Angels group, possibly to be in conjunction with HBS Angels
7:45-8:00+: Networking among attendees and speakers
Speakers & Topics:
Louis A. Bevilacqua, Partner, Pillsbury Winthrop Shaw Pittman LLP:
Crowdfunding- what does it mean? How easy will it really be? Who will benefit? What are the risks? What are the effects of the new JOBS Act, just enacted into law, on lowering regulatory hurdles for
Grant Allen, Vice President, ABB Technology Ventures
Venture perspective- US overall and DC Region in particular, advice for companies looking to raise money (pitches, business plans, etc.)
Manpreet Singh, COO, Seva Search:
Startup perspective from a startup exec, specifically challenges of raising money in DC area and advice for companies looking to do so
Paul Sherman, Co-founder & Editor-in-Chief, Tech Wire Publications:
Macro perspective- trends in the types of companies getting funded, outlook for the next few years
Speakers:
Louis A. Bevilacqua, Partner, Pillsbury Winthrop Shaw Pittman LLP
Pillsbury is a major full-service, global law firm, with offices in leading cities in the U.S. and abroad. Based in the firm's DC and Shanghai offices, Louis Bevilacqua has broad experience in public offerings and pri-
In addition to working with NYSE- and NASDAQ-listed companies, Lou has several years of experience working with microcap and nanocap public companies whose securities are quoted on the over-the-counter Bulletin Board, and he understands the special needs of these companies. He also represents companies with international operations, including companies based in the People's Republic of China and Taiwan, Republic of China, Latin America, Europe and Australia.
Lou has significant experience advising life sciences companies including vaccine and other pharmaceutical companies, medical device companies and medical products and medical disposables manufacturers. He also advises emerging technology driven companies on licensing and development transactions, joint ventures, technology-transfers and related intellectual property matters.
|
